Similarly, in breast cancer and melanoma, NSUN2 overexpression correlates with advanced stage and metastasis; NSUN2 can methylate mRNAs or even tRNA-derived fragments that regulate cell motility and cytoskeletal dynamics, thereby facilitating metastatic spread [107,108]. This evidence concerns the gene NSUN2 and melanoma.